[Immunotherapy using P. aeruginosa: type III secretion system-based live bacterial vector]

Med Mal Infect. 2008 Jun:38 Suppl 2:S87-9. doi: 10.1016/S0399-077X(08)73002-6.
[Article in French]
No abstract available

MeSH terms

  • Genetic Vectors
  • Humans
  • Immunotherapy / methods*
  • Opportunistic Infections / immunology
  • Opportunistic Infections / microbiology
  • Pseudomonas Infections / immunology*
  • Pseudomonas aeruginosa / immunology*
  • Virulence